Tandem Diabetes Care, Inc. (TNDM)

Tandem Diabetes Care Stock Forecast

Stock Price Forecast

The 15 analysts with 12-month price forecasts for Tandem Diabetes Care stock have an average target of 46.07, with a low estimate of 22 and a high estimate of 75. The average target predicts an increase of 127.84% from the current stock price of 20.22.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$22	$46.07	$53	$75
Change	+8.80%	+127.84%	+162.12%	+270.92%

Analyst Ratings

The average analyst rating for Tandem Diabetes Care stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	5	5	5	5	5	4
Buy	6	7	8	8	8	6
Hold	4	4	3	3	2	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	16	16	16	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Patrick Wood Morgan Stanley	Morgan Stanley	Buy → Hold Downgrades $45 → $22	Buy → Hold	Downgrades	$45 → $22	+8.80%	Mar 5, 2025
Joanne Wuensch Citigroup	Citigroup	Strong Buy → Hold Downgrades $35 → $24	Strong Buy → Hold	Downgrades	$35 → $24	+18.69%	Mar 4, 2025
David Roman Goldman Sachs	Goldman Sachs	Hold Maintains $42 → $24	Hold	Maintains	$42 → $24	+18.69%	Mar 3, 2025
Larry Biegelsen Wells Fargo	Wells Fargo	Buy → Hold Downgrades $38 → $22	Buy → Hold	Downgrades	$38 → $22	+8.80%	Mar 3, 2025
Matt Miksic Barclays	Barclays	Buy Maintains $60 → $53	Buy	Maintains	$60 → $53	+162.12%	Feb 28, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.02B

Increased by 8.70%

from 940.20M

Revenue Next Year

1.14B

Increased by 11.06%

from 1.02B

EPS This Year

-1.25

from -1.47

EPS Next Year

-0.76

from -1.25

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	498.83M	702.80M	801.22M	747.72M	940.20M	1.02B	1.14B	1.25B
Revenue Growth	37.68%	40.89%	14.00%	-6.68%	25.74%	8.70%	11.06%	9.87%
EPS	-0.56	0.24	-1.47	-3.43	-1.47	-1.25	-0.76	-0.35
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	26	22	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	1.1B	1.2B	1.3B
Avg	1.0B	1.1B	1.2B
Low	965.7M	1.1B	1.1B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	14.8%	19.1%	17.4%
Avg	8.7%	11.1%	9.9%
Low	2.7%	3.6%	-0.4%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.81	-0.28	0.12
Avg	-1.25	-0.76	-0.35
Low	-1.48	-1.11	-0.76

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.